Associate Director, HCP Marketing, LUMRYZ
Alkermes · Waltham, MA
$165k–$195k/yrHybrid

Bicara TherapeuticsBoston, MAFull-timeHybridPosted 1 month ago
$231k–$269k/yr listed by the employer
On Bicara Therapeutics’ own careers site (Ashby).
Summarised from the posting by AI and can be wrong. The full description is the source.
Sign in and add your resume to see which of this job's requirements it shows.
Sign in to check your matchSaved to your account, encrypted. The AI that reads it doesn't keep it or train on it.
From Bicara Therapeutics’ careers site
POSITION OVERVIEW
Bicara Therapeutics is seeking a Director, Healthcare Professional Marketing (HCP) Lead to develop, lead, and execute HCP marketing strategy and promotions for Bicara’s lead candidate, Ficerafusp Alfa. The HCP marketing director will be a critical part of the launch readiness team and work closely with the Senior Director, Marketing to develop commercial HCP promotion strategy and tactical plans for Ficerafusp Alfa in Head and Neck Squamous Cell Carcinoma (HNSCC) within the US.
This is a high-impact, highly visible role that partners closely with Commercial Strategy, Commercial Operations, Market Access, Medical Affairs, Insights & Analytics, Legal & Compliance, Competitive Intelligence, Sales, and Training. This role will also involve managing agency partners and overseeing workstreams that involve broad and meaningful internal and external collaboration.
This role is based in our Boston office and follows a hybrid schedule, with three in-office days each week.
RESPONSIBILITIES
QUALIFICATIONS
COMPANY OVERVIEW
Bicara Therapeutics is a clinical-stage biotech company pioneering bifunctional antibodies for targeted tumor modulation. Founded in 2020, we've built a global team of over 100 employees headquartered in Boston, with a clear focus on advancing our lead asset, ficerafusp alfa, or FICERA - a potentially first-in-class bifunctional EGFR-directed antibody combined with a TGF-β ligand trap. Our innovative approach combines tumor-targeting with tumor modulation, where one arm localizes to the tumor while the other serves as a modulator, designed to deliver superior efficacy, improved safety, and enhanced durability directly at the tumor site. FICERA specifically addresses a key challenge in solid tumor treatment by enabling immune cell penetration into tumors, reducing fibrosis and immunosuppression while reversing TGF-β-driven resistance mechanisms - ultimately designed to drive the deep, durable responses that may translate into better outcomes and survival for patients. For more information, please visit www.bicara.com http://www.bicara.com.
Here at Bicara, we believe in building diverse teams and cultivating a culture where all voices are included. We encourage people from all backgrounds to apply.
Bicara Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.
Something wrong with this job? Report it · This flag looks wrong
Alkermes · Waltham, MA
$165k–$195k/yrHybrid
StrongChecked open todayPosted 1 month ago

Xometry · Waltham, MA +3 places
$175k–$200k/yrHybrid
StrongChecked open todayPosted 25 days ago

Recorded Future · Boston, MA +1 place
$167k–$234k/yrFull-timeHybrid
StrongChecked open todayPosted 11 days ago
Beam Therapeutics · Cambridge, MA
$185k–$225k/yrFull-time
StrongChecked open todayPosted 29 days ago
Grant Thornton US · Chicago, IL +34 places
$184k–$276k/yrHybrid
StrongChecked open todayPosted 1 month ago
Rhythm Pharmaceuticals · Boston, MA
$160k–$240k/yrFull-timeHybrid
StrongChecked open todayPosted 20 days ago